TDI01

Recent news mentioning TDI01

• 2026-08-26 — Graviton BioScience Corporation Announces Publication of Positive Ph1b Trial Results for GV101 (TDI01) in Chronic Graft versus Host Disease in Signal Transduction and Targeted Therapy, by Beijing Tide Pharmaceutical

Appears alongside

• BioScience
• GV101

Browse the full archive →